Search hospitals > Louisiana > Baton Rouge
LSU Health Baton Rouge-North Clinic
Claim this profileBaton Rouge, Louisiana 70805
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Pancreatic Cancer
92 reported clinical trials
4 medical researchers
Summary
LSU Health Baton Rouge-North Clinic is a medical facility located in Baton Rouge, Louisiana. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Pancreatic Cancer and other specialties. LSU Health Baton Rouge-North Clinic is involved with conducting 92 clinical trials across 156 conditions. There are 4 research doctors associated with this hospital, such as Marshall P. Stagg, David S. Hanson, Augusto C. Ochoa, and Nakhle Saba.Area of expertise
1Lung Cancer
Global LeaderStage II
Stage I
Stage IV
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
Marshall P. StaggLSU Health Baton Rouge-North Clinic2 years of reported clinical research
Studies Lung Cancer
Studies Cancer
41 reported clinical trials
85 drugs studied
David S. HansonMary Bird Perkins Cancer Center6 years of reported clinical research
Expert in Lung Cancer
Studies Breast Cancer
38 reported clinical trials
82 drugs studied
Augusto C. OchoaLouisiana State University Health Science Center8 years of reported clinical research
Studies Breast cancer
Studies Breast Cancer
19 reported clinical trials
75 drugs studied
Nakhle SabaTulane Cancer Center8 years of reported clinical research
Studies Lymphoma
Studies Mixed-Cell Lymphoma
17 reported clinical trials
42 drugs studied
Clinical Trials running at LSU Health Baton Rouge-North Clinic
Lung Cancer
Skin Cancer
Ovarian Cancer
Prostate Cancer
Cancer
Bladder Cancer
Uterine Cancer
Pancreatic Cancer
Multiple Myeloma
Acute Myeloid Leukemia
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Pembrolizumab + Sacituzumab Tirumotecan
for Lung Cancer
This study will assess if adding sacituzumab tirumotecan with pembrolizumab after surgery is effective in treating NSCLC for participants not achieving pathological complete response. The primary hypothesis of this study is sacituzumab tirumotecan plus pembrolizumab is superior to pembrolizumab monotherapy with respect to disease free survival (DFS) as assessed by blinded independent central review (BICR).
Recruiting2 awards Phase 3
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at LSU Health Baton Rouge-North Clinic?
LSU Health Baton Rouge-North Clinic is a medical facility located in Baton Rouge, Louisiana. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Pancreatic Cancer and other specialties. LSU Health Baton Rouge-North Clinic is involved with conducting 92 clinical trials across 156 conditions. There are 4 research doctors associated with this hospital, such as Marshall P. Stagg, David S. Hanson, Augusto C. Ochoa, and Nakhle Saba.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.